When you purchase products or services through our links we and our partners earn a small commission. Thank you.

Final Trades: GXO, Becton Dickinson, Freeport-McMoRan & more

#IJH #GXO #BDX #FCX

For access to live and exclusive video from CNBC subscribe to CNBC PRO

» Subscribe to CNBC TV
» Subscribe to CNBC

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
✔️ Get the latest news
✔️ Follow CNBC on LinkedIn
✔️ Follow CNBC News on Facebook
✔️ Follow CNBC News on Twitter
✔️ Follow CNBC News on Instagram

🔷 Join The Smoking Chair on Facebook
🇺🇸 Join Partisan For The People on Facebook

iShares Trust - iShares Core S&p Mid-Cap ETF (NYSEMKT: IJH)

Company: The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the S&P MidCap 400 (the underlying index).

The index measures the performance of the mid-capitalization sector of the U.S. equity market, as determined by SPDJI. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.

Research: IJH

GXO Logistics (NYSE: GXO)

Company: GXO Logistics, Inc., together with its subsidiaries, provides logistics services worldwide. The company provides warehousing and distribution, order fulfilment, e-commerce, and other supply chain services, as well as reverse logistics or returns management services. As of December 31, 2021, it operated in approximately 906 facilities. The company serves various customers in the e-commerce, omnichannel retail, consumer technology, food and beverage, industrial and manufacturing, and consumer packaged goods industries. GXO Logistics, Inc. was incorporated in 2021 and is headquartered in Greenwich, Connecticut.

Research: GXO

Becton, Dickinson And (NYSE: BDX)

Company: Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company’s BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company’s BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Research: BDX

Freeport-McMoRan (NYSE: FCX)

Company: Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia. The company primarily explores for copper, gold, molybdenum, silver, and other metals, as well as oil and gas. Its assets include the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, and Miami in Arizona; Tyrone and Chino in New Mexico; and Henderson and Climax in Colorado, North America, as well as Cerro Verde in Peru and El Abra in Chile. The company also operates a portfolio of oil and gas properties primarily located in offshore California and the Gulf of Mexico. As of December 31, 2021, it operated approximately 135 wells. The company was formerly known as Freeport-McMoRan Copper & Gold Inc. and changed its name to Freeport-McMoRan Inc. in July 2014. Freeport-McMoRan Inc. was incorporated in 1987 and is headquartered in Phoenix, Arizona.

Research: FCX

Financial Disclaimer
All opinions expressed by the Show Participants are solely their current opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company, the author, TheSmokingChair.com or any of their related companies or affiliates or the companies with which the Show Participants or author are affiliated and may have been previously disseminated by them. The Show Participants’ and author’s opinions are based upon information they consider reliable, but neither CNBC or TheSmokingChair.com, nor their affiliates and/or subsidiaries, nor the companies with which such participants are affiliated, warrant its completeness or accuracy, and it should not be relied upon as such. No part of the Show Participants’ or author’s compensation from CNBC or TheSmokingChair.com is related to the specific opinions they express.

Past performance is not indicative of future results. Neither the Show Participants nor CNBC nor TheSmokingChair.com or its authors guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on the show. Strategies or investments discussed may fluctuate in price or value.

Investments or strategies mentioned in this show may not be suitable for you and you should make your own independent decision regarding them. This material does not take into account your particular investment objectives, financial situation or needs and is not intended as recommendations appropriate for you. You should strongly consider seeking advice from your own investment adviser.